| Therapeutic Dose Monitoring (TDM) of Tamoxifen (NCT05133674) | Karolinska University Hospital | 2022-04-04 |
| Phase 2 Study of Imprime PGG and Pembrolizumab in Patients With HR+/HER2- Metastatic Breast Cancer (mBCA) (NCT05159778) | HiberCell, Inc. | 2021-11-09 |
| Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer Survivors (NCT05364450) | Indiana University | 2021-08-17 |
| Swedish Ibrance Registries Insights (SIRI) (NCT04654208) | Pfizer | 2020-12-15 |
| Breast Reconstruction Following Breast Cancer in Very High Risk Patients (NCT03261323) | Case Comprehensive Cancer Center | 2019-05-31 |
| Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT (NCT03435952) | M.D. Anderson Cancer Center | 2018-07-10 |
| Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBC (NCT03289819) | Institut fuer Frauengesundheit | 2018-03-23 |
| Phase 1 Study to Evaluate the Effect of DS-8201a on the QT/QTc Interval and Pharmacokinetics in HER2-Expressing Breast Cancer (NCT03366428) | Daiichi Sankyo Co., Ltd. | 2017-12-26 |
| Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast Cancer (NCT03379428) | US Oncology Research | 2017-11-29 |
| Selumetinib and Olaparib in Solid Tumors (NCT03162627) | M.D. Anderson Cancer Center | 2017-08-04 |
| Ibrance Real World Insights (NCT03159195) | Pfizer | 2017-06-12 |
| Lenvatinib and Capecitabine in Patients With Advanced Malignancies (NCT02915172) | M.D. Anderson Cancer Center | 2016-12-01 |
| Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant Treatment (NCT02891681) | Washington University School of Medicine | 2016-11-29 |
| Comparing Efficacy and Safety of AryoGen Pharmed Biosimilar Trastuzumab (AryoTrust) Versus Herceptin® in Breast Cancer (NCT03425656) | AryoGen Pharmed Co. | 2016-07-09 |
| Investigation of Three Approaches to Address Fear of Recurrence Among Breast Cancer Survivors (NCT02611544) | Indiana University | 2015-12-01 |
| MIRs03: Paravertebral Block With Ropivacaine Before Breast Cancer Surgery (NCT02408393) | Institut Curie | 2015-03-27 |
| Analgesic Effects of Ultrasound Guided PEC Blocks on Analgesic Opioid Consumption of Cancer Surgery Patients (NCT02495363) | Rabin Medical Center | 2015-03-01 |
| Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy (NCT02204098) | Washington University School of Medicine | 2015-01-07 |
| Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality (NCT02378337) | Hospital Sao Rafael | 2014-09-01 |
| Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer (NCT02101385) | Bryan Schneider, MD | 2014-04-03 |
| Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer (NCT01953003) | Pierre Fabre Medicament | 2013-09-01 |
| Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors (NCT01639911) | University of Illinois at Chicago | 2013-08-14 |
| Isolation and Characterization of Cancer Stem Cells Using iFP Technique (NCT01641003) | Rambam Health Care Campus | 2012-07-01 |
| ICG Fluorescence Technique for the Detection of Sentinel Lymph Nodes (NCT01395706) | Pulsion Medical Systems SE | 2011-09-01 |
| Discordant Hormonal Status of Breast Cancer. (NCT01943032) | National Cancer Institute, Thailand | 2011-04-01 |
| Discordant HER2/Neu Status of Breast Cancer. (NCT01935739) | National Cancer Institute, Thailand | 2010-06-01 |